Hydrafacial Results Presentation Deck slide image

Hydrafacial Results Presentation Deck

Beauty Health March 31, 2022 (unless otherwise stated) Cash and Cash Equivalents Warrants Convertible Debt Revolving Credit Facility BALANCE SHEET HIGHLIGHTS Shares Outstanding ■ ■ ■ ■ ■ ■ ■ $859.2 million cash and cash equivalents on balance sheet¹ Approximately 7 million Private Warrants outstanding $750 million 1.25% convertible notes due 2026 Use of proceeds: capped call transaction, potential future acquisitions, working capital expenditures, and general corporate purposes Conversion price of $31.76; capped call agreement provides dilution protection up to $47.94 $50 million Senior Secured Credit Facility remains undrawn; current undrawn commitment fee of 25 bps Allows flexibility for future M&A; ex-US operations unencumbered; convertible debt. excluded from covenants Approximately 151 million current shares outstanding2 Ample liquidity to invest in the Beauty Health community and pursue disciplined M&A 18 Includes proceeds from $750 million convertible debt issued in September 2021; 2 As of 05/04/22 8
View entire presentation